关键词：皮肤病；痤疮；牛皮癣；用药；口服药物；新型生物药物
摘 要：Dermatological disorders are skin diseases caused due to the imbalance in the physiological condition of the skin. Some of the common dermatological disorders are acne, psoriasis, and dermatitis. While psoriasis is a lifelong skin condition caused by changes in the immune system, acne is caused due to the changes in hormone levels in the body. Dermatitis is caused by both genetic and environmental factors. Topical medications, oral medications, new biologic drugs, or a combination of these are some of the treatment options available for dermatological disorders.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Type

07.1 Global Psoriasis Drugs Market

07.1.1 Market Size and Forecast

07.2 Global Acne Drugs Market

07.2.1 Market Size and Forecast

07.3 Global Dermatitis Drugs Market

07.3.1 Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Rate of Incidence and Prevalence

Global Incidence and Prevalence of Psoriasis

Global Incidence and Prevalence of Acne

Global Incidence and Prevalence of Dermatitis

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 AbbVie Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Galderma SA

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Johnson & Johnson Ltd.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Novartis AG

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Stiefel Laboratories Inc.

18.5.1 Business Overview

18.5.2 Key Information

18.5.3 SWOT Analysis

18.6 Valeant Pharmaceuticals International Inc.

18.6.1 Business Overview

18.6.2 Business Segmentation

18.6.3 Key Information

18.6.4 SWOT Analysis

19. Other Reports in this Series